THERAPEUTICS
Review: antioxidant supplements do not reduce all-cause mortality in primary or secondary prevention
| The first 150 words of the full text of this article appear below. |
G Bjelakovic
Dr G Bjelakovic, Copenhagen University Hospital, Copenhagen, Denmark. goranb@junis.ni.ac.yu
QUESTION
Do antioxidant supplements reduce all-cause mortality in primary or secondary prevention?
REVIEW SCOPE
Included studies compared antioxidant supplements (β-carotene, vitamin A, vitamin C, vitamin E, or selenium) with placebo or no intervention in healthy participants (primary prevention) or in patients with any disease (secondary prevention) who were
18 years of age. Studies of patients with acute, infectious, or malignant diseases (except non-melanoma skin cancer), or of children or pregnant women, were excluded. Outcome was all-cause mortality.
REVIEW METHODS
MEDLINE, EMBASE/Excerpta Medica, and Science Citation Index Expanded (all to Oct 2005); Cochrane Library (Issue 3, 2005); and reference lists were searched for randomised controlled trials (RCTs). Pharmaceutical companies were contacted. 67 RCTs (n = 232 550, mean age 62 y, 55% men, based on 63 RCTs) met the selection criteria: 21 RCTs (n = 164 439) included healthy participants, and 46 RCTs (n =
Pacific Palisades Medical Group, Malibu, California, USA
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
